|
시장보고서
상품코드
2109028
비타민 K2 시장 : 기능별, 생산 기술별, 제품 유형별, 원료별, 용도별, 적용 형태별, 지역별 예측(-2031년)Vitamin K2 Market by Application (Health Supplements, Functional Food & Beverages, Pharmaceutical), Product Type (MK-7, MK-4), Application Form (Capsules & Tablets, Powder & Crystalline, Liquids), Source, Function, and Region - Global Forecast to 2031 |
||||||
비타민 K2 시장 규모는 2026년 1억 7,900만 달러에서 2031년까지 3억 3,990만 달러에 이를 것으로 예측되며, 2026년부터 2031년까지 연평균 복합 성장률(CAGR)은 13.7%를 나타낼 전망입니다.
이러한 성장은 뼈 및 심혈관 건강에 대한 소비자의 인식 제고, 예방 의료에 대한 수요 증가, 그리고 영양 보조제 및 기능성 식품의 보급 확대에 의해 주도되고 있습니다. 소비자들은 장기적인 건강과 웰빙을 점점 더 중요하게 여기게 되었으며, 그 결과 칼슘 대사, 뼈의 석회화 및 심혈관 건강을 지원하는 비타민 K2 원료에 대한 수요가 증가하고 있습니다.
| 조사 범위 | |
|---|---|
| 조사 대상 기간 | 2022-2031년 |
| 기준 연도 | 2025년 |
| 예측 기간 | 2026-2031년 |
| 산정 단위 | 금액(100만 달러), 수량(1,000톤) |
| 부문 | 기능별, 생산기술별, 제품 유형별, 유래별, 용도별, 적용 형태별, 지역별 |
| 대상 지역 | 북미, 유럽, 아시아태평양, 기타 지역 |
또한, 과학적으로 입증된 클린 라벨 천연 유래 성분에 대한 수요가 높아짐에 따라, 영양 보조 식품, 기능성 식품 및 음료, 의약품 용도에서 발효 유래 비타민 K2의 채택이 확대되고 있습니다. 고령화의 진행, 골다공증 및 심혈관 질환 발병률 증가, 의료비 증가가 선진국 및 신흥국 시장의 확장을 더욱 뒷받침하고 있습니다.
각 제조업체는 비타민 K2 원료의 순도, 안정성 및 생체 이용률을 향상시키기 위해 제품 혁신과 첨단 생산 기술에 대한 투자를 지속하고 있습니다. 끊임없이 변화하는 고객 및 규제 요건에 대응하기 위해, 자연 발효, 화학 합성 및 생명 공학을 활용한 발효 기술을 통해 고품질 MK7 및 MK4 제제 개발에 주력하는 움직임이 강화되고 있습니다. 정제 공정, 마이크로캡슐화 기술 및 제형 솔루션의 발전으로 제조업체들은 원료의 안정성을 높이고 다양한 제품 형태로의 적용 범위를 넓힐 수 있게 되었습니다. 또한, 과학적 연구 증가, 규제 당국의 승인 확대, 그리고 맞춤형 영양 솔루션 및 기능성 건강 제품에 비타민 K2의 채택 확대가 시장 진출기업들에게 새로운 성장 기회를 창출하고 있습니다. 그러나 엄격한 규제 요건, 개발도상국 소비자의 낮은 인지도, 원자재 및 생산 비용, 제조업체 간 경쟁 심화 등의 과제가 시장 성장을 저해할 가능성이 있습니다.
'제품 유형별로는 MK-7 부문이 시장에서 주요 부문이 될 것으로 예측됩니다.'
제품 유형별로는 MK-7 부문이 시장을 주도할 것으로 예측됩니다. 비타민 K2 MK-7, 특히 MenaQ7 및 vitaMK7은 영양 과학 분야의 획기적인 진보로, 뼈 건강과 심혈관 건강 양면에서 효과가 있는 것으로 알려져 있습니다. K1과 달리, K2 MK-7은 생체 이용률이 뛰어나고 체내 반감기가 긴 특징을 가지고 있어, 뼈의 강도를 높이기 위한 칼슘 이용을 촉진하는 동시에 동맥 석회화를 예방하는 데 최적입니다. 오스테오칼신이나 매트릭스 GLA 단백질(MGP)과 같은 주요 단백질의 활성화에 있어 K2 MK-7이 수행하는 역할은 골격의 건전성과 심혈관계의 유연성을 유지하는 데 있어 그 효능을 입증하고 있습니다. 소비자의 건강 의식이 높아지고 식이 영양 결핍이 여전히 지속되는 가운데, 다양한 인구층의 근본적인 건강 문제를 해결하는 과학적으로 입증된 보충제에 대한 수요가 증가함에 따라 K2 MK-7 시장의 잠재력은 계속해서 확대되고 있습니다.
'비타민 K2 시장의 의약품 분야는 예측 기간 동안 상당한 성장이 예상됩니다.'
비타민 K2는 의약품 용도에서 다양한 잠재적 이점이 확인되고 있으며, 이것이 업계 내 이 성분에 대한 수요를 견인할 것으로 예측됩니다. 그러나 지역을 불문하고 의약품 용도로의 비타민 K2 사용에는 엄격한 규제 체계가 존재합니다. 다양한 비타민 K2 제조업체의 주요 업계 전문가들은 의약품 용도로의 비타민 K2 사용이 아시아태평양으로 한정되어 있다는 점에 의견을 같이하고 있습니다. 이 지역 내에서는 일부 국가가 의약품 용도의 비타민 K2를 생산하고 있으나, 그 소비는 주로 중국과 일본에서 확인되고 있습니다. 따라서 최근 정부의 견해와 진행 중인 조사 및 임상시험은 의약품 용도에서 비타민 K2의 잠재적 이점을 뒷받침하고 있습니다.
'예측 기간 동안 아시아태평양은 전 세계 비타민 K2 시장에서 가장 빠르게 성장하는 지역이 될 것으로 전망됩니다.'
아시아태평양은 인구 통계, 경제, 생활 방식 등의 요인이 복합적으로 작용하여 비타민 K2 시장에서 가장 빠르게 성장하는 시장으로 부상하고 있습니다. 이러한 성장의 주요 성장 촉진요인 중 하나는 해당 지역의 급속한 고령화입니다. 일본, 중국, 한국 등의 국가에서는 골다공증이나 심혈관 질환과 같은 뼈 관련 질환에 걸리기 쉬운 고령 인구가 크게 증가하고 있습니다. 이러한 인구 통계학적 변화로 인해 뼈 건강을 지원하고 동맥 석회화를 예방하는 영양 보충제에 대한 수요가 크게 높아지고 있으며, 비타민 K2는 수요가 높은 영양소로 자리 잡고 있습니다.
또한, 아시아태평양(APAC) 지역의 전자상거래(EC) 부문의 강력한 성장으로 인해 다양한 비타민 K2 제품에 대한 접근성이 크게 향상되어 시장 확대에 기여하고 있습니다. 주요 이점 중 하나는 아마존(Amazon), 알리바바(Alibaba) 및 기타 지역의 주요 전자상거래 기업과 같은 온라인 소매 플랫폼의 보급입니다. 이러한 플랫폼은 비타민 K2 보충제의 인지도를 높였을 뿐만 아니라, 더 광범위한 유통망을 구축하여 가장 외딴 지역에 거주하는 소비자에게도 제품을 전달할 수 있게 했습니다.
시장의 주요 기업으로는 Gnosis by Lesaffre(프랑스), Balchem Corporation(미국), J-OIL MILLS, INC.(일본), Novonesis A/S(덴마크), Guangdong Sungen Bioscience(중국), Vesta Nutra(미국) 등이 있습니다.
조사 범위
본 조사 보고서에서는 비타민 K2 시장을 제품 유형(MK4 및 MK7), 제형(캡슐·정제, 분말·결정, 액체), 원료(천연 및 합성), 용도(의약품, 기능성 식품 및 음료, 건강보조식품), 기능(골격 및 심혈관 건강, 혈액 건강 및 응고, 항염증 및 면역, 기타 기능), 제조 기술(천연 발효, 화학 합성, 생명공학 발효, 기타 제조 기술), 지역(북미, 유럽, 아시아태평양, 기타 지역)별로 분류하고 있습니다.
본 보고서의 조사 범위에는 비타민 K2 산업의 성장에 영향을 미치는 주요 요인(촉진요인, 제약 요인, 과제 및 기회 등)에 대한 상세한 정보가 포함되어 있습니다. 주요 업계 기업에 대한 철저한 분석을 통해 그들의 사업, 서비스, 주요 전략, 계약, 제휴, 합의, 신규 서비스 출시, 합병 및 인수, 그리고 비타민 K2 시장과 관련된 최근 동향에 대한 인사이트를 제공합니다. 본 보고서에서는 비타민 K2 시장 생태계에서 부상하고 있는 신생 스타트업 기업의 경쟁 분석도 수록했습니다. 또한, 본 조사에서는 기술 분석, 생태계 및 시장 매핑, 특허·규제 현황 등 업계 특유의 동향에 대해서도 종합적으로 다루고 있습니다.
본 보고서를 구매해야 하는 이유
본 보고서는 시장 선도 기업 및 신규 진출기업에게 비타민 K2 시장 전체 및 그 하위 부문의 매출에 대한 가장 정확한 추정치를 제공합니다. 이를 통해 이해관계자는 경쟁 구도를 이해하고, 자사의 비즈니스를 더 나은 위치로 이끌며, 적절한 시장 진출 전략을 수립하기 위한 추가적인 인사이트를 얻을 수 있습니다. 또한, 본 보고서는 이해관계자가 시장 동향을 파악하는 데 도움이 되며, 주요 시장 성장 촉진요인, 억제요인, 과제 및 기회에 대한 정보를 제공합니다.
본 보고서는 다음 사항에 대한 인사이트를 제공합니다.
- 비타민 K2 시장의 성장에 영향을 미치는 주요 성장 촉진요인(소비자의 건강 의식 고조), 제약 요인(규제 기준의 불일치), 기회(천연 및 식물 유래 원료에 대한 수요 증가), 과제(비타민 K2의 구체적인 건강 효과에 대한 소비자의 인식 부족)에 대한 분석
- 제품 개발/혁신 : 비타민 K2 시장의 연구 개발 활동 및 신제품 출시에 대한 상세한 분석
- 시장 개발 : 다양한 지역별 비타민 K2 수익성 높은 시장 분석에 관한 종합적인 정보
- 시장 다각화 : 비타민 K2 시장의 새로운 제품 공급원, 미개척 지역, 최근 동향 및 투자에 관한 종합적인 정보
- 경쟁사 평가 : Lesaffre사의 Gnosis(프랑스), Balchem Corporation(미국), J-OIL MILLS, INC.(일본), Novonesis A/S(덴마크), Guangdong Sungen Bioscience(중국), Vesta Nutra(미국), Shandong Richen Nutritional Technology(중국), Menadiona S.L.(스페인), GF Fermentech(한국), Angel Yeast(중국), GeneFerm Biotechnology(대만), Nakoda Chemicals Ltd.(인도), Haihang Industry(중국), Chemicea Limited(인도), Kyowa Hakko U.S.A., Inc.(미국) 등 주요 기업의 시장 점유율, 성장 전략, 제품 라인업, 브랜드·제품 비교, 그리고 비타민 K2 시장에서의 제품 전개 상황에 대해
자주 묻는 질문
목차
제1장 서론
제2장 주요 요약
제3장 프리미엄 인사이트
제4장 시장 개요
제5장 업계 동향
제6장 기술 진보, AI의 영향, 특허, 혁신, 향후 응용
제7장 규제 상황과 지속가능성 이니셔티브
제8장 고객 현황과 구매 행동
제9장 비타민 K2 시장(기능별)
제10장 비타민 K2 시장(생산 기술별)
제11장 비타민 K2 시장(제품 유형별)
제12장 비타민 K2 시장(유래별)
제13장 비타민 K2 시장(용도별)
제14장 비타민 K2 시장(적용 형태별)
제15장 비타민 K2 시장(지역별)
제16장 경쟁 구도
제17장 기업 개요
제18장 조사 방법
제19장 인접 시장 및 관련 시장
제20장 부록
KTH 26.08.20The Vitamin K2 market is projected to reach USD 339.9 million by 2031 from USD 179.0 million in 2026, at a CAGR of 13.7% from 2026 to 2031. This growth is propelled by increasing awareness of consumers regarding bone and cardiovascular health, increasing demand for preventive healthcare, and rising adoption of dietary supplements and functional nutrition products. Consumers are increasingly prioritizing long-term health and wellness, resulting in higher demand for Vitamin K2 ingredients that support calcium metabolism, bone mineralization, and cardiovascular health.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2022-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD MN), Volume (KT) |
| Segments | by Application, Product Type, Application Form, Source, Function, and Region |
| Regions covered | North America, Europe, APAC, RoW |
In addition, the growing preference for scientifically validated, clean-label, and naturally derived ingredients is encouraging the adoption of fermentation-based Vitamin K2 across dietary supplements, functional foods and beverages, and pharmaceutical applications. The expanding aging population, increasing incidence of osteoporosis and cardiovascular disorders, and rising healthcare expenditure are further supporting market expansion across developed and emerging economies.
Manufacturers are continuously investing in product innovation and advanced production technologies to improve the purity, stability, and bioavailability of Vitamin K2 ingredients. There is a growing focus on developing high-quality MK7 and MK4 formulations through natural fermentation, chemical synthesis, and biotechnological fermentation technologies to meet evolving customer and regulatory requirements. Advancements in purifying processes, microencapsulation technologies, and formulation solutions are enabling manufacturers to enhance ingredient stability and application diversity across multiple product formats. Additionally, increasing scientific research, expanding regulatory approvals, and growing incorporation of Vitamin K2 into personalized nutrition solutions and functional health products are creating new growth opportunities for market participants. However, challenges such as stringent regulatory requirements, limited consumer awareness in developing regions, raw material and production costs, and increasing competition among manufacturers may restrain market growth.
"By product type, the MK-7 segment is expected to be the dominant segment in the market."
By product type, the MK-7 segment is projected to be the dominant segment in the market. Vitamin K2 MK7, specifically MenaQ7 and vitaMK7, represents a pivotal advancement in nutritional science, renowned for its dual benefits in bone and cardiovascular health. Distinct from its K1 counterpart, K2 MK-7's superior bioavailability and extended half-life in the body make it optimal for promoting calcium utilization towards bone strength while preventing arterial calcification. Its role in activating key proteins like osteocalcin and Matrix Gla Protein (MGP) underscores its efficacy in supporting skeletal integrity and cardiovascular flexibility. As consumer awareness grows and dietary deficiencies persist, the market potential for K2 MK-7 continues to expand, driven by increasing demand for scientifically validated supplements that address fundamental health challenges across diverse demographic segments.
"The pharmaceuticals segment in the Vitamin K2 market is projected to have significant growth during the forecast period."
Vitamin K2 has shown various potential benefits in pharmaceutical applications, which are expected to drive demand for this ingredient in the industry. However, there is a stringent regulatory structure for the usage of Vitamin K2 in pharmaceutical applications across regions. Multiple primary industry experts from various Vitamin K2 manufacturers agreed that the usage of Vitamin K2 in pharmaceutical applications is limited to Asia Pacific; within this region, although some countries manufacture Vitamin K2 for pharmaceutical applications, the consumption is mainly observed in China and Japan. Thus, recent government insights, along with ongoing research and clinical trials, support the potential benefits of Vitamin K2 in pharmaceutical applications.
"Asia Pacific is projected to be the fastest-growing region in the global Vitamin K2 market during the forecast period."
The Asia Pacific region is emerging as the fastest-growing market for Vitamin K2, driven by a combination of demographic, economic, and lifestyle factors. One of the primary drivers of this growth is the region's rapidly aging population. Countries such as Japan, China, and South Korea are experiencing significant increases in their elderly populations, who are more prone to bone-related ailments like osteoporosis and cardiovascular issues. This demographic shift is creating a substantial demand for nutritional supplements that support bone health and prevent arterial calcification, making Vitamin K2 a sought-after nutrient.
Additionally, the robust growth of the e-commerce sector in the Asia Pacific (APAC) region has significantly facilitated easy access to a wide range of Vitamin K2 products, contributing to the market's expansion. One of the main advantages is the proliferation of online retail platforms, such as Amazon, Alibaba, and other regional e-commerce giants. These platforms have not only increased the visibility of Vitamin K2 supplements but have also allowed for a broader distribution network, reaching consumers in even the most remote areas.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Vitamin K2 market.
- By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
- By Designation: CXOs - 25%, Managers - 35%, Others - 40%
Prominent companies in the market include Gnosis by Lesaffre (France), Balchem Corporation (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), and others.
Research Coverage
This research report categorizes the Vitamin K2 market by product type (MK4 and MK7), application form (capsules and tablets, powder and crystalline, and liquids), source (natural and synthetic), application (pharmaceuticals, functional foods and beverages, and health supplements), function (bone and cardiovascular health, blood health and clotting, anti-inflammatory and immunity, and other functions), processing technology (natural fermentation, chemical synthesis, biotechnological fermentation, and other production technologies) and region (North America, Europe, Asia Pacific, and Rest of the World).
The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Vitamin K2 industry. A thorough analysis of the key industry players has been carried out to provide insights into their business, services, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the Vitamin K2 market. This report provides a competitive analysis of emerging startups in the Vitamin K2 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.
Reasons to Buy This Report
The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall Vitamin K2 and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (rising health consciousness among consumers), restraints (inconsistency in regulatory norms), opportunities (growing demand for natural and plant-based ingredients), and challenges (lack of consumer awareness regarding specific health benefits of Vitamin k2) influencing the growth of the Vitamin K2 market
- Product Development/Innovation: Detailed insights into research & development activities and product launches in the Vitamin K2 market
- Market Development: Comprehensive information about lucrative market analysis of Vitamin K2 across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the Vitamin K2 market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Gnosis by Lesaffre (France), Balchem Corporation (US), J-OIL MILLS, INC. (Japan), Novonesis A/S (Denmark), Guangdong Sungen Bioscience Co., Ltd. (China), Vesta Nutra (US), Shandong Richen Nutritional Technology Co., Ltd. (China), Menadiona S.L. (Spain), GF Fermentech Co., Ltd. (South Korea), Angel Yeast Co., Ltd. (China), GeneFerm Biotechnology Co., Ltd. (Taiwan), Nakoda Chemicals Ltd. (India), Haihang Industry Co., Ltd. (China), Chemicea Limited (India), and Kyowa Hakko U.S.A., Inc. (US) in the Vitamin K2 market
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE AND SEGMENTATION
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
- 1.3.5 UNIT CONSIDERED
- 1.4 STAKEHOLDERS
- 1.5 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN VITAMIN K2 MARKET
- 2.4 HIGH-GROWTH SEGMENTS
- 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
- 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VITAMIN K2 MARKET
- 3.2 VITAMIN K2 MARKET, BY APPLICATION FORM AND REGION
- 3.3 VITAMIN K2 MARKET, BY SOURCE
- 3.4 VITAMIN K2 MARKET, BY APPLICATION
- 3.5 VITAMIN K2 MARKET, BY PRODUCT TYPE
- 3.6 VITAMIN K2 MARKET, BY APPLICATION FORM
- 3.7 VITAMIN K2 MARKET, BY COUNTRY
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Rising health consciousness among consumers
- 4.2.1.2 Increasing research and development activities
- 4.2.1.3 Growing aging population and rising prevalence of bone & cardiovascular disorders
- 4.2.2 RESTRAINTS
- 4.2.2.1 Inconsistency in regulatory norms
- 4.2.2.2 Price volatility of raw materials
- 4.2.3 OPPORTUNITIES
- 4.2.3.1 Growing demand for natural and plant-based ingredients
- 4.2.3.2 Rising need for personalized nutrition and customized products
- 4.2.3.3 Untapped applications
- 4.2.4 CHALLENGES
- 4.2.4.1 Lack of consumer awareness regarding specific health benefits
- 4.2.4.2 High research and development costs
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS AND WHITE SPACES
- 4.3.1 UNMET NEEDS IN VITAMIN K2 MARKET
- 4.3.2 WHITE SPACE OPPORTUNITIES
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.4.1 INTERCONNECTED MARKETS
- 4.4.2 CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
- 4.5.1 KEY MOVES AND STRATEGIC FOCUS
5 INDUSTRY TRENDS
- 5.1 PORTER'S FIVE FORCES ANALYSIS
- 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.1.2 BARGAINING POWER OF SUPPLIERS
- 5.1.3 BARGAINING POWER OF BUYERS
- 5.1.4 THREAT OF SUBSTITUTES
- 5.1.5 THREAT OF NEW ENTRANTS
- 5.2 MACROECONOMICS OUTLOOK
- 5.2.1 INTRODUCTION
- 5.2.1.1 Macroeconomic indicators
- 5.2.1.1.1 Rising world GDP and population
- 5.2.1.1.2 Rise in health concerns and disease incidences
- 5.2.1.1 Macroeconomic indicators
- 5.2.1 INTRODUCTION
- 5.3 VALUE CHAIN ANALYSIS
- 5.3.1 RESEARCH AND DEVELOPMENT
- 5.3.2 RAW MATERIAL SOURCING
- 5.3.3 PRODUCTION AND PROCESSING
- 5.3.4 QUALITY ASSURANCE
- 5.3.5 MARKETING, DISTRIBUTION, & SALES
- 5.3.6 END USERS
- 5.4 ECOSYSTEM ANALYSIS
- 5.4.1 DEMAND SIDE
- 5.4.2 SUPPLY SIDE
- 5.5 PRICING ANALYSIS
- 5.5.1 INTRODUCTION
- 5.5.2 AVERAGE SELLING PRICE (ASP) TREND, BY PRODUCT TYPE, 2022-2025 (USD/TONS)
- 5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TONS)
- 5.6 TRADE ANALYSIS
- 5.6.1 IMPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
- 5.6.2 EXPORT ANALYSIS: VITAMINS AND THEIR DERIVATIVES
- 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
- 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.9 INVESTMENT AND FUNDING SCENARIO
- 5.10 CASE STUDY ANALYSIS
- 5.10.1 GNOSIS BY LESAFFRE - LAUNCH OF MENAQ7 OLIVE OIL
- 5.10.2 BALCHEM CORP.- ACQUISITION OF KAPPA BIOSCIENCE
- 5.11 IMPACT OF 2025 US TARIFF - VITAMIN K2 MARKET
- 5.11.1 INTRODUCTION
- 5.11.2 PRICE IMPACT ANALYSIS
- 5.11.3 IMPACT ON COUNTRIES/REGIONS
- 5.11.3.1 US
- 5.11.3.2 Europe
- 5.11.3.3 Asia Pacific
- 5.11.4 IMPACT ON END-USE INDUSTRIES
6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
- 6.1 TECHNOLOGY ANALYSIS
- 6.1.1 KEY TECHNOLOGIES
- 6.1.1.1 Fermentation technology
- 6.1.1.2 Bioreactor process control technology
- 6.1.2 COMPLEMENTARY ANALYSIS
- 6.1.2.1 Encapsulation technology
- 6.1.2.2 Spray drying technology
- 6.1.3 ADJACENT TECHNOLOGIES
- 6.1.3.1 Synthetic biology
- 6.1.3.2 Continuous manufacturing technology
- 6.1.4 TECHNOLOGY/PRODUCT ROADMAP
- 6.1.4.1 Short-term | Process optimization & high-purity ingredient expansion
- 6.1.4.2 Mid-term | Personalized nutrition & sustainable bioprocessing
- 6.1.4.3 Long-term | Synthetic biology & next-generation precision health
- 6.1.1 KEY TECHNOLOGIES
- 6.2 PATENT ANALYSIS
- 6.3 FUTURE APPLICATIONS
- 6.3.1 AI-DRIVEN PRECISION FERMENTATION: OPTIMIZING VITAMIN K2 PRODUCTION
- 6.3.2 SYNTHETIC BIOLOGY: ENGINEERING HIGH-PERFORMANCE MICROBIAL STRAINS
- 6.3.3 PRECISION NUTRITION & PERSONALIZED SUPPLEMENTATION: ADVANCING PREVENTIVE HEALTHCARE
- 6.3.4 ADVANCED DELIVERY SYSTEMS & SMART FORMULATIONS: IMPROVING BIOAVAILABILITY
- 6.3.5 DIGITAL MANUFACTURING & SMART QUALITY CONTROL: ENHANCING PRODUCTION EFFICIENCY
- 6.4 IMPACT OF GENERATIVE AI ON VITAMIN K2 MARKET
- 6.4.1 INTRODUCTION
- 6.4.2 CASE STUDIES OF AI IMPLEMENTATION IN VITAMIN K2 MARKET
- 6.4.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 6.4.4 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN VITAMIN K2 MARKET
- 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
- 7.1 REGIONAL REGULATIONS AND COMPLIANCE
- 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 7.1.2 INDUSTRY STANDARDS
- 7.1.3 LABELING REQUIREMENTS AND CLAIMS
- 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
- 7.1.4.1 Enhanced ingredient traceability and supply chain transparency
- 7.1.4.2 Greater harmonization of global regulatory standards
- 7.1.4.3 Stricter sustainability and responsible manufacturing requirements
- 7.1.4.4 Digital compliance, smart manufacturing, and quality management
- 7.1.4.5 Expanded regulation of novel production technologies and health claims
- 7.1.4.6 Strengthened labeling and consumer transparency requirements
- 7.2 SUSTAINABILITY INITIATIVES
- 7.2.1 SUSTAINABLE SOURCING
- 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
- 7.2.3 CIRCULAR ECONOMY APPROACHES
- 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
- 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
- 8.1 DECISION-MAKING PROCESS
- 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
- 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 8.2.2 BUYING CRITERIA
- 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
- 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
- 8.5 MARKET PROFITABILITY
- 8.6 REVENUE POTENTIAL
- 8.6.1 COST DYNAMICS
- 8.6.2 MARGIN OPPORTUNITIES, BY PRODUCT TYPE
9 VITAMIN K2 MARKET, BY FUNCTION
- 9.1 INTRODUCTION
- 9.2 BONE AND CARDIOVASCULAR HEALTH
- 9.2.1 RISING PREVALENCE OF OSTEOPOROSIS AND CARDIOVASCULAR DISORDERS TO DRIVE VITAMIN K2 ADOPTION IN BONE AND CARDIOVASCULAR HEALTH FORMULATIONS
- 9.3 BLOOD HEALTH AND CLOTTING
- 9.3.1 EFFICACY IN MANAGING CLOTTING DISORDERS TO BOOST MARKET GROWTH
- 9.4 ANTI-INFLAMMATORY AND IMMUNITY
- 9.4.1 THERAPEUTIC POTENTIAL AND IMMUNITY-SUPPORTING PROPERTIES TO SUPPORT MARKET GROWTH
- 9.5 OTHER FUNCTIONS
10 VITAMIN K2 MARKET, BY PRODUCTION TECHNOLOGY
- 10.1 INTRODUCTION
- 10.2 NATURAL FERMENTATION
- 10.2.1 PREFERRED PRODUCTION TECHNOLOGY FOR PREMIUM VITAMIN K2 (MK-7) DUE TO SUPERIOR BIOAVAILABILITY, NATURAL ORIGIN, AND STRONG CONSUMER ACCEPTANCE
- 10.3 CHEMICAL SYNTHESIS
- 10.3.1 COST-EFFECTIVE PRODUCTION AND HIGH MANUFACTURING SCALABILITY, PARTICULARLY FOR VITAMIN K2 (MK-4)
- 10.4 BIOTECHNOLOGICAL FERMENTATION
- 10.4.1 ENHANCES PRODUCTION EFFICIENCY THROUGH ADVANCED MICROBIAL ENGINEERING AND PRECISION BIOPROCESS TECHNOLOGIES
- 10.5 OTHER PRODUCTION TECHNOLOGIES
11 VITAMIN K2 MARKET, BY PRODUCT TYPE
- 11.1 INTRODUCTION
- 11.2 MK7
- 11.2.1 HIGH BIOAVAILABILITY TO PROPEL MARKET GROWTH
- 11.3 MK4
- 11.3.1 POTENTIAL BENEFITS IN BONE AND CARDIOVASCULAR HEALTH TO DRIVE MARKET
12 VITAMIN K2 MARKET, BY SOURCE
- 12.1 INTRODUCTION
- 12.2 NATURAL
- 12.2.1 INCREASING CONSUMER PREFERENCE FOR NON-GMO SUPPLEMENTS TO BOOST MARKET GROWTH
- 12.3 SYNTHETIC
- 12.3.1 LOW PRODUCTION COST TO DRIVE MARKET
13 VITAMIN K2 MARKET, BY APPLICATION
- 13.1 INTRODUCTION
- 13.2 HEALTH SUPPLEMENTS
- 13.2.1 GROWING ADOPTION OF PREVENTIVE NUTRITION AND CLINICALLY SUPPORTED DIETARY SUPPLEMENTS TO DRIVE SEGMENT
- 13.3 FUNCTIONAL FOOD & BEVERAGES
- 13.3.1 GROWING DEMAND FOR FORTIFIED FUNCTIONAL FOODS TO PROPEL MARKET GROWTH
- 13.4 PHARMACEUTICALS
- 13.4.1 RISING INVESTMENTS FOR DEVELOPING NEW FORMULATIONS TO DRIVE MARKET
14 VITAMIN K2 MARKET, BY APPLICATION FORM
- 14.1 INTRODUCTION
- 14.2 CAPSULES & TABLETS
- 14.2.1 ABILITY TO CATER TO DIVERSE CONSUMER NEEDS AND PREFERENCES TO DRIVE MARKET
- 14.3 POWDER & CRYSTALLINE
- 14.3.1 SURGING DEMAND FOR CUSTOMIZABLE DOSAGES AND HIGH PURITY TO PROPEL MARKET GROWTH
- 14.4 LIQUIDS
- 14.4.1 GROWING NEED FOR SUPPLEMENTS WITH ENHANCED BIOAVAILABILITY TO BOOST SEGMENT GROWTH
15 VITAMIN K2 MARKET, BY REGION
- 15.1 INTRODUCTION
- 15.2 NORTH AMERICA
- 15.2.1 US
- 15.2.1.1 Growing awareness about preventive health measures to drive market
- 15.2.2 CANADA
- 15.2.2.1 Increasing focus on preventive healthcare and natural products to propel market
- 15.2.3 MEXICO
- 15.2.3.1 High prevalence of chronic lifestyle diseases to drive market
- 15.2.1 US
- 15.3 EUROPE
- 15.3.1 GERMANY
- 15.3.1.1 Rising focus on proactive healthcare to drive market
- 15.3.2 FRANCE
- 15.3.2.1 Investments in R&D and product innovation to boost market growth
- 15.3.3 UK
- 15.3.3.1 Rapidly aging population to propel market growth
- 15.3.4 ITALY
- 15.3.4.1 Aging population and preventive healthcare trends to support vitamin K2 adoption
- 15.3.5 SPAIN
- 15.3.5.1 Growing consumer interest in health supplements to drive demand
- 15.3.6 REST OF EUROPE
- 15.3.1 GERMANY
- 15.4 ASIA PACIFIC
- 15.4.1 CHINA
- 15.4.1.1 Surging use of digital media to disseminate healthcare information to propel market
- 15.4.2 JAPAN
- 15.4.2.1 Consumer preferences for natural healthcare solutions to boost market growth
- 15.4.3 INDIA
- 15.4.3.1 Strategic market penetration initiatives by various companies to drive market
- 15.4.4 AUSTRALIA AND NEW ZEALAND
- 15.4.4.1 Changing consumer preferences and increasing health consciousness to drive demand
- 15.4.5 REST OF ASIA PACIFIC
- 15.4.1 CHINA
- 15.5 REST OF THE WORLD
- 15.5.1 SOUTH AMERICA
- 15.5.1.1 Rising preventive healthcare awareness and expanding nutraceutical industry to support market growth
- 15.5.2 MIDDLE EAST & AFRICA
- 15.5.2.1 Rising healthcare investments and growing preventive nutrition awareness to support market growth
- 15.5.1 SOUTH AMERICA
16 COMPETITIVE LANDSCAPE
- 16.1 OVERVIEW
- 16.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN 2021-2026
- 16.3 REVENUE ANALYSIS, 2023-2025
- 16.4 MARKET SHARE ANALYSIS, 2025
- 16.4.1 BRAND COMPARISON
- 16.4.2 NOVONESIS GROUP (MENAQUINGOLD)
- 16.4.3 GNOSIS BY LESAFFRE (MENAQ7)
- 16.4.4 BALCHEM CORP. (K2VITAL)
- 16.4.5 GUANGDONG SUNGEN BIOSCIENCE CO., LTD. (ESSEK2)
- 16.4.6 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.) (MENNATO)
- 16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
- 16.5.1 STARS
- 16.5.2 EMERGING LEADERS
- 16.5.3 PERVASIVE PLAYERS
- 16.5.4 PARTICIPANTS
- 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
- 16.5.5.1 Company footprint
- 16.5.5.2 Region footprint
- 16.5.5.3 Application footprint
- 16.5.5.4 Product type footprint
- 16.6 COMPANY EVALUATION MATRIX: DISTRIBUTORS/SUPPLIERS
- 16.6.1 PROGRESSIVE COMPANIES
- 16.6.2 RESPONSIVE COMPANIES
- 16.6.3 DYNAMIC COMPANIES
- 16.6.4 STARTING BLOCKS
- 16.6.5 COMPETITIVE BENCHMARKING: DISTRIBUTORS/SUPPLIERS, 2025
- 16.6.5.1 Detailed list of key distributors/suppliers
- 16.6.5.2 Competitive benchmarking of key distributors/suppliers
- 16.7 COMPANY VALUATION AND FINANCIAL METRICS
- 16.7.1 COMPANY VALUATION
- 16.7.2 EV/EBITDA
- 16.8 COMPETITIVE SCENARIO
- 16.8.1 PRODUCT LAUNCHES/DEVELOPMENTS
- 16.8.2 DEALS
- 16.8.3 EXPANSIONS
- 16.8.4 OTHER DEVELOPMENTS
17 COMPANY PROFILES
- 17.1 KEY PLAYERS (MANUFACTURERS)
- 17.1.1 GNOSIS BY LESAFFRE
- 17.1.1.1 Business overview
- 17.1.1.2 Products/Solutions/Services offered
- 17.1.1.3 Recent developments
- 17.1.1.3.1 Product launches/developments
- 17.1.1.3.2 Deals
- 17.1.1.4 MnM view
- 17.1.1.4.1 Right to win
- 17.1.1.4.2 Strategic choices
- 17.1.1.4.3 Weaknesses and competitive threats
- 17.1.2 BALCHEM CORP.
- 17.1.2.1 Business overview
- 17.1.2.2 Products/Solutions/Services offered
- 17.1.2.3 Recent developments
- 17.1.2.3.1 Product launches/developments
- 17.1.2.3.2 Deals
- 17.1.2.3.3 Expansions
- 17.1.2.4 MnM view
- 17.1.2.4.1 Right to win
- 17.1.2.4.2 Strategic choices
- 17.1.2.4.3 Weaknesses and competitive threats
- 17.1.3 J-OIL MILLS, INC. (PLT HEALTH SOLUTIONS, INC.)
- 17.1.3.1 Business overview
- 17.1.3.2 Products/Solutions/Services offered
- 17.1.3.3 Recent developments
- 17.1.3.3.1 Product launches/developments
- 17.1.3.3.2 Deals
- 17.1.3.4 MnM view
- 17.1.3.4.1 Right to win
- 17.1.3.4.2 Strategic choices
- 17.1.3.4.3 Weaknesses and competitive threats
- 17.1.4 NOVONESIS GROUP
- 17.1.4.1 Business overview
- 17.1.4.2 Products/Solutions/Services offered
- 17.1.4.3 Recent developments
- 17.1.4.3.1 Deals
- 17.1.4.4 MnM view
- 17.1.4.4.1 Right to win
- 17.1.4.4.2 Strategic choices
- 17.1.4.4.3 Weaknesses and competitive threats
- 17.1.5 GUANGDONG SUNGEN BIOSCIENCE CO., LTD.
- 17.1.5.1 Business overview
- 17.1.5.2 Products/Solutions/Services offered
- 17.1.5.3 Recent developments
- 17.1.5.3.1 Other developments
- 17.1.5.4 MnM view
- 17.1.5.4.1 Right to win
- 17.1.5.4.2 Strategic choices
- 17.1.5.4.3 Weaknesses and competitive threats
- 17.1.6 VESTA NUTRA
- 17.1.6.1 Business overview
- 17.1.6.2 Products/Solutions/Services offered
- 17.1.6.3 Recent developments
- 17.1.6.4 MnM view
- 17.1.7 RICHEN NUTRITIONAL TECHNOLOGY CO., LTD.
- 17.1.7.1 Business overview
- 17.1.7.2 Products/Solutions/Services offered
- 17.1.7.3 Recent developments
- 17.1.7.3.1 Product launches/developments
- 17.1.7.3.2 Other developments
- 17.1.7.4 MnM view
- 17.1.8 MENADIONA
- 17.1.8.1 Business overview
- 17.1.8.2 Products/Solutions/Services offered
- 17.1.8.3 Recent developments
- 17.1.8.3.1 Product launches/developments
- 17.1.8.4 MnM view
- 17.1.9 GF FERMENTECH CO., LTD.
- 17.1.9.1 Business overview
- 17.1.9.2 Products/Solutions/Services offered
- 17.1.9.3 Recent developments
- 17.1.9.3.1 Product launches/developments
- 17.1.9.3.2 Deals
- 17.1.9.4 MnM view
- 17.1.10 ANGELYEAST CO., LTD.
- 17.1.10.1 Business overview
- 17.1.10.2 Products/Solutions/Services offered
- 17.1.10.3 Recent developments
- 17.1.10.3.1 Expansions
- 17.1.10.4 MnM view
- 17.1.11 GENEFERM BIOTECHNOLOGY CO., LTD.
- 17.1.11.1 Business overview
- 17.1.11.2 Products/Solutions/Services offered
- 17.1.11.3 Recent developments
- 17.1.11.3.1 Expansions
- 17.1.11.4 MnM view
- 17.1.12 NAKODA CHEMICALS LTD.
- 17.1.12.1 Business overview
- 17.1.12.2 Products/Solutions/Services offered
- 17.1.12.3 Recent developments
- 17.1.12.4 MnM view
- 17.1.13 HAIHANG INDUSTRY CO., LTD.
- 17.1.13.1 Business overview
- 17.1.13.2 Products/Solutions/Services offered
- 17.1.13.3 Recent developments
- 17.1.13.4 MnM view
- 17.1.14 CHEMICEA LIMITED
- 17.1.14.1 Business overview
- 17.1.14.2 Products/Solutions/Services offered
- 17.1.14.3 Recent developments
- 17.1.14.4 MnM view
- 17.1.15 KYOWA HAKKO U.S.A., INC.
- 17.1.15.1 Business overview
- 17.1.15.2 Products/Solutions/Services offered
- 17.1.15.3 Recent developments
- 17.1.15.4 MnM view
- 17.1.1 GNOSIS BY LESAFFRE
- 17.2 DISTRIBUTORS/SUPPLIERS
- 17.2.1 SEEBIO BIOTECH (SHANGHAI) CO., LTD.
- 17.2.2 MAGNESIA GMBH
- 17.2.3 FALCON TRADING INTERNATIONAL
- 17.2.4 ABCO INDIA
- 17.2.5 ATLANTIC CHEMICALS TRADING GMBH
18 RESEARCH METHODOLOGY
- 18.1 RESEARCH DATA
- 18.1.1 SECONDARY DATA
- 18.1.1.1 Key data from secondary sources
- 18.1.2 PRIMARY DATA
- 18.1.2.1 Key data from primary sources
- 18.1.2.2 Breakdown of primary profiles
- 18.1.2.3 Key insights from industry experts
- 18.1.1 SECONDARY DATA
- 18.2 MARKET SIZE ESTIMATION
- 18.2.1 TOP-DOWN APPROACH
- 18.2.2 SUPPLY-SIDE ANALYSIS
- 18.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
- 18.3 DATA TRIANGULATION AND MARKET BREAKUP
- 18.4 RESEARCH ASSUMPTIONS
- 18.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
19 ADJACENT AND RELATED MARKETS
- 19.1 INTRODUCTION
- 19.2 RESEARCH LIMITATIONS
- 19.3 DIETARY SUPPLEMENTS MARKET
- 19.3.1 MARKET DEFINITION
- 19.3.2 MARKET OVERVIEW
- 19.4 VITAMINS MARKET
- 19.4.1 MARKET DEFINITION
- 19.4.2 MARKET OVERVIEW
20 APPENDIX
- 20.1 DISCUSSION GUIDE
- 20.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 20.3 CUSTOMIZATION OPTIONS
- 20.4 RELATED REPORTS
- 20.5 AUTHOR DETAILS
